SCHEMBL4907504

SCHEMBL4907504

CCOC(=O)c1ccc2nc[nH]c2c1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.46
ATM Q13315 1/20 0.46
KDM4E B2RXH2 4/20 0.43
NUDT1 P36639 1/20 0.43
ALDH1A1 P00352 3/20 0.43
TSHR P16473 2/20 0.42
CLEC4M Q9H2X3 1/20 0.42
HPGD P15428 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 1/20 0.41
TP53 P04637 1/20 0.41
RAB9A P51151 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MEN1 O00255 1/20 0.41
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4914364 0.99 KMT2A (0.45) KMT2AATMKDM4ENUDT1ALDH1A1
SCHEMBL4081935 0.80 CLEC4M (0.57) KMT2AATMKDM4ENUDT1ALDH1A1
SCHEMBL4907498 0.78 KDM4E (0.44) KMT2AATMKDM4ENUDT1ALDH1A1
Hydrochloric Acid SCHEMBL4914353 0.77 KDM4E (0.43) KMT2AATMKDM4ENUDT1ALDH1A1
SCHEMBL18313853 0.75 ALDH1A1 (0.44) KMT2AATMKDM4EALDH1A1HPGD
SCHEMBL10337048 0.72 ATM (0.51) KMT2AATMKDM4ENUDT1ALDH1A1
SCHEMBL4921740 0.72 ATM (0.51) KMT2AATMKDM4ENUDT1ALDH1A1
SCHEMBL3412270 0.72 MEN1 (0.52) KMT2AKDM4EALDH1A1TSHRMEN1
SCHEMBL13961675 0.72 KDM4E (0.43) KMT2AATMKDM4ENUDT1ALDH1A1
SCHEMBL31124713 0.72 KDM4E (0.47) KDM4EALDH1A1SMN1; SMN2NPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080103138-A1 Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-05-01 US disclosed
US-20070112033-A1 N-(3-{2-[3-(6-amino-benzimidazol-1-yl)-1,1-dimethyl-propylamino]-1-hydroxy-ethyl}-phenyl)-benzenesulphonamide; beta(3)-Adrenoceptor agonists; antidiabetic, obesity, insulin resistance BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080103138-A1 Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions ADRB1, ADRB3, ADRB2 KMT2A 4734/4885ATM 4192/4885KDM4E 4614/4885
US-20070112033-A1 N-(3-{2-[3-(6-amino-benzimidazol-1-yl)-1,1-dimethyl-propylamino]-1-hydroxy-ethyl}-phenyl)-benzenesulphonamide; beta(3)-Adrenoceptor agonists; antidiabetic, obesity, insulin resistance ADRB3, ADRB1, ADRA1B KMT2A 4585/4885ATM 2964/4885KDM4E 4097/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.